Docetaxel/5'DFUR or Docetaxel for advanced or recurrent gastric cancer as 2nd line chemotherapy
Not Applicable
- Conditions
- gastric cancer
- Registration Number
- JPRN-C000000025
- Lead Sponsor
- Shinshu Gastroenterological Cancer Study Group
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Sex
- All
- Target Recruitment
- 110
Inclusion Criteria
Not provided
Exclusion Criteria
1. serious complications 2. infection 3. peripheral neuropathy 4. other cancers (except cured cancer) 5. brain metastasis 6. severe pleural effusion or severe ascites 7. allergy to polysorbate 80 8. drug allergy 9. pregnant or lactational
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method